000 01241 a2200325 4500
005 20250517152938.0
264 0 _c20190731
008 201907s 0 0 eng d
022 _a1097-685X
024 7 _a10.1016/j.jtcvs.2017.03.085
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSmeltzer, Matthew P
245 0 0 _aSurvival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United States.
_h[electronic resource]
260 _bThe Journal of thoracic and cardiovascular surgery
_c08 2017
300 _a661-672.e10 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCarcinoma, Non-Small-Cell Lung
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCombined Modality Therapy
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
650 0 4 _aPostoperative Period
650 0 4 _aUnited States
700 1 _aLin, Chun Chieh
700 1 _aKong, Feng-Ming Spring
700 1 _aJemal, Ahmedin
700 1 _aOsarogiagbon, Raymond U
773 0 _tThe Journal of thoracic and cardiovascular surgery
_gvol. 154
_gno. 2
_gp. 661-672.e10
856 4 0 _uhttps://doi.org/10.1016/j.jtcvs.2017.03.085
_zAvailable from publisher's website
999 _c27152861
_d27152861